Search results
At Aadi Bioscience, our mission is to improve the lives of people with mTOR-driven diseases. We believe success depends on addressing the limitations of current mTOR inhibitors and leveraging the latest genomic profiling technology to identify the patients most likely to benefit from mTOR inhibition. Learn More.
- Pipeline
Registration-intended; Fully enrolled as of May 2024;...
- The Company
Aadi Bioscience, Inc. is a commercial-stage...
- Leadership
Neil Desai, PhD Founder, CEO and President Dr. Desai is the...
- Board of Directors
Neil Desai, PhDFounder, CEO and President Dr. Desai is the...
- mTOR Pathway
Aadi Bioscience’s lead investigational drug candidate...
- Publications and Abstracts
Select PublicationsWagner AJ, Ravi V, Riedel RF, et al....
- Our Medicine
Learn More at FYARRO.com Medical Information, Adverse Event...
- Advanced Malignant PEComa
Fast Facts Malignant PEComa is an ultra-rare sarcoma that...
- Pipeline
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations, in which other mTOR inhibitors have not or cannot be effectively exploited due to problems of ...
Neil Desai, PhD Founder, CEO and President Dr. Desai is the founder of Aadi and has served as Aadi’s President, Chief Executive Officer, and Chairman of Aadi’s board of directors since Aadi’s founding in October 2011. He is an inventor of the nab® technology, Abraxane®, and FyarroTM.
Aadi Bioscience Inc. (Aadi) is a biopharmaceutical company focused on precision therapies for genetically-defined cancers. We strive to unleash the potential of mTOR inhibition by...
Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively ...
- Pacific Palisades, California
- Neil Desai
- Aadi Bioscience is located in Pacific Palisades, California, United States.
- Aadi Bioscience has 19 investors including KVP Capital And Alerce Medical Technology Partners.
- Aadi Bioscience has raised $250.5M.
- Aadi Bioscience closed its last funding round on Sep 22, 2022 from a Post-IPO Equity round.
- Alternatives and possible competitors to Aadi Bioscience may include Day One Biopharmaceuticals, Iroko Pharmaceuticals, And Enliven Therapeutics.
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes.
People also ask
Who is Aadi Bioscience?
How many followers does Aadi Bioscience have?
Where is Aadi BioScience headquartered?
What does Aadi do?
Dec 14, 2023 · Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR...
